Ireland
--:--IST
Latest
Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide
Priya Life Science Clinical trial register
TrackersDrugsComparisonsAPI
Trackers› Clinical trials› Umeå
Clinical trial register · Sweden

Clinical Trials in Umeå, 2026

Every study on the ClinicalTrials.gov registry that lists a site in Sweden and is open, about to open, active-but-closed, or enrolling by invitation. Filter it, cite it, and take it away as a file.

Download CSV
Source: ClinicalTrials.gov, U.S. National Library of Medicine. Complete coverage — all 2219 matching records held by the registry are in this view. Synced 12 Oct 2026, 03:19 UTC
2219
Studies in scope
all four open statuses
1247
Recruiting now
open to new participants
367
Lead sponsors
across recruiting studies
Top sites
Stockholm 930 Gothenburg 631 Lund 404 Uppsala 369 Linköping 236
Narrow the registerReset
Recruitment status
Phase
Lead sponsor
Umeå University49 Karolinska Institutet11 AstraZeneca8 Uppsala University6 Region Skane6
Site location
Stockholm930 Gothenburg631 Lund404 Uppsala369 Linköping236
All 146 locations
Target enrolment
to

Trials with a site in Umeå

195 of 2219 studies
Download
Status
Study
Lead sponsor
Phase
Enrol
Sites in Sweden
Start
Not yet open
Sahlgrenska University Hospital
Phase 4
216
Malmö, Huddinge, Stockholm, Uppsala, Umeå, Sundsvall, Mölndal, Skövde
2027-01-11
Not yet open
Development of a Pain Rehabilitation Program for Chronic Pain After SCI
NCT07634796Spinal Cord Injuries, Chronic Pain, Neuropathic Pain, Interprofessional Team Collaboration
Umeå University
Not applicable
32
Umeå
2026-10-01
Not yet open
Urban Arnelo
Not applicable
8
Umeå
2026-10
Not yet open
Umeå University
Not applicable
28
Umeå
2026-09-30
Not yet open
REcovery After Cancer Application
NCT07642492Oesophageal Cancer, Gastric Cancer (Diagnosis)
Karolinska Institutet
Not applicable
250
Gothenburg, Linköping, Lund, Örebro, Stockholm, Umeå, Uppsala
2026-09-15
Recruiting
John Neoptolemos
Phase 3
394
Huddinge, Linköping, Malmö, Umeå, Uppsala
2026-08-17
Not yet open
Heart Failure and Postoperative Outcome in Surgery - a National Registry Study
NCT07634822Heart Failure, Diastolic Heart Failure, Systolic Heart Failure
Umeå University
Observational
2,200,000
Luleå, Umeå
2026-08
Recruiting
Umeå University
Not applicable
248
Umeå
2026-06-03
Recruiting
AstraZeneca
Phase 3
670
Stockholm, Umeå
2026-05-04
Recruiting
Monopolar Basivertebral Nerve Ablation for Axial Low Back Pain
NCT07559890Chronic Back Pain, Basivertebral Nerve Ablation
EPC Education s.r.o.
Not applicable
100
Umeå
2026-05-04
Not yet open
Long-Term Outcomes After CDI: FMT Versus Antibiotic-Only Treatment
NCT07569380Clostridioides Difficile Infection
Umeå University
Observational
250
Umeå
2026-05-01
Recruiting
Umeå University
Observational
150
Umeå
2026-04-10
Recruiting
Roberto Valente
Not applicable
178
Umeå
2026-04-09
Recruiting
Selenium Intervention Registry Randomized Trial in Heart Failure
NCT07543562Heart Failure, Heart Failure and Reduced Ejection Fraction, Heart Failure and Mildly Reduced Ejection Fraction, Heart Failure and Preserved Ejection Fraction
Skane University Hospital
Phase 3
4,326
Malmö, Gothenburg, Jönköping, Linköping, Lund, Örebro, Stockholm, Umeå
2026-04-01
Not yet open
Menopausal Impact of Opportunistic Salpingectomy for Ovarian Cancer Prevention
NCT07423143Menopause, Opportunistic Salpingectomy
Umeå University
Not applicable
2,100
Umeå
2026-03
Recruiting
Blended Trauma-Focused Cognitive Behavioral Therapy With Compassion
NCT07407946Post-traumatic Stress Disorder (PTSD)
Umeå University
Not applicable
40
Umeå
2026-02-23
Recruiting
Alnylam Pharmaceuticals
Phase 3
125
Stockholm, Umeå
2026-02-03
Recruiting
Robotic-Assisted Pedicle Screw Placement in Spine Surgery
NCT07461636Pedicle Screw Fixation of Spine
Uppsala University
Observational
7,200
Gothenburg, Jönköping, Kalmar, Linköping, Örebro, Stockholm, Umeå, Uppsala
2026-02-02
Not yet open
VDJ-recombination of the B-cell Receptor Following Hematopoietic Stem Cell Transplantation
NCT07346820Stem Cell Transplantation, Hematopoietic, V(D)J Recombination, Receptors, Antigen, B-Cel
Umeå University
Observational
65
Umeå
2026-02-01
Not yet open
Increased Pacemaker Lower Rate in ATTR Cardiac Amyloidosis
NCT07413081Cardiac Amyloidosis, Pacemaker
Region Skane
Not applicable
34
Gothenburg, Linköping, Lund, Skellefteå, Stockholm, Umeå, Uppsala
2026-02-01
Recruiting
Prilenia
Phase 3
500
Stockholm, Umeå
2026-02-01
Recruiting
Clostridioides Difficile: Understanding Responses and Treatment Effects
NCT07374094Clostridioides Difficile Infection
Umeå University
Observational
200
Umeå
2026-01-26
Recruiting
Umeå University
Observational
150
Umeå
2026-01-21
Recruiting
Novo Nordisk A/S
Phase 3
460
Umeå, Uppsala
2026-01-08
Recruiting
Single-Stapled Technique for Colorectal Anastomosis
NCT07417358Colorectal Cancer, Colorectal Anastomosis, Anastomotic Leakage, Diverticular Disease of Left Side of Colon
Umeå University
Observational
500
Gothenburg, Luleå, Malmö, Umeå, Uppsala
2026-01-07
Recruiting
AstraZeneca
Phase 3
1,100
Linköping, Lund, Solna, Umeå, Uppsala
2025-12-29
Recruiting
Study on Orthosis in Cervical Spine Fracture Treatment
NCT06848660Cervical Spine Fractures, Cervical Spine Injury, Rigid Collar
Uppsala University Hospital
Not applicable
616
Gothenburg, Linköping, Lund, Malmö, Umeå, Uppsala
2025-11-01
Active, closed
STAR-C Digital Coaching Intervention
NCT05864001Healthy Lifestyle
Umeå University
Not applicable
56
Umeå
2025-10-16
Recruiting
Region Västerbotten
Observational
300
Umeå
2025-10-06
Recruiting
Novo Nordisk A/S
Phase 3
1,280
Huddinge, Umeå
2025-10-02
Recruiting
Postoperative Nausea, Vomiting and Pain After Bariatric Surgery - a National Registry Study
NCT07797374Postoperative Nausea and Vomiting, Postoperative Pain, Obesity, Morbid, Bariatric Surgery
Umeå University
Observational
30,000
Sundsvall, Umeå
2025-10-01
Recruiting
Preoptimisation in Ventral Hernia Surgery
NCT07316426Hernia, Hernia, Ventral, Hernia Incisional, Hernia, Umbilical
Umeå University
Not applicable
130
Gällivare, Luleå, Lycksele, Skellefteå, Umeå
2025-09-22
Recruiting
Uppsala University
Not applicable
96
Kalmar, Linköping, Malmö, Örebro, Stockholm, Umeå, Uppsala
2025-09-17
Recruiting
Zydus Therapeutics Inc.
Phase 2
240
Malmö, Stockholm, Umeå
2025-09-17
Recruiting
Sustained Cord Circulation at Emergency Cesarean Section
NCT06540222Asphyxia Neonatorum, Fetal Hypoxia
Region Skane
Not applicable
2,200
Gothenburg, Halmstad, Linköping, Lund, Malmö, Örebro, Stockholm, Umeå
2025-09-08
By invitation
Unsteady Gait in Older People May be a Common and Treatable Neurological Disease Associated With Increased Mortality
NCT07137403Idiopathic Normal Pressure Hydrocephalus (INPH), Gait Disorders, Neurologic, Gait Disorders in Old Age
Umeå University
Observational
450
Umeå
2025-09-01
Recruiting
AstraZeneca
Phase 3
700
Gothenburg, Malmö, Stockholm, Umeå, Uppsala
2025-08-06
Recruiting
AstraZeneca
Phase 3
15,100
Alingsås, Falun, Huddinge, Lidköping, Lund, Östersund, Stockholm, Umeå
2025-06-04
Recruiting
Region Stockholm
Phase 3
1,600
Linköping, Örebro, Stockholm, Umeå, Uppsala
2025-06-03
Recruiting
Acoramidis Transthyretin Amyloidosis Prevention Trial in the Young (ACT-EARLY) Study in Asymptomatic Carriers of a Pathogenic TTR Variant
NCT06563895Amyloidosis, Amyloid Cardiomyopathy, Transthyretin Amyloidosis, Cardiomyopathies
DrugAcoramidis
Eidos Therapeutics, a BridgeBio company
Phase 3
587
Umeå
2025-05-12
Recruiting
Registry-randomized Comparison of Rehabilitation Regimens After Flexor Tendon Injury in the Thumb
NCT06836349Flexor Tendon Injury, Rehabilitation Program, Flexor Tendon Rupture, Thumb Injury
Karolinska Institutet
Not applicable
380
Linköping, Örebro, Stockholm, Umeå, Uppsala
2025-05-01
Recruiting
taVNS AB
Not applicable
128
Lund, Malmö, Örebro, Stockholm, Umeå
2025-03-21
Recruiting
Thrombolysis in Factor Xa-inhibitors Trial
NCT06878066Stroke, Stroke (in Patients With Atrial Fibrillation), Ischemic Stroke, Acute Ischemic Stroke
DrugsAlteplase·Tenecteplase
Guri Hagberg
Phase 3
300
Stockholm, Lund, Malmö, Umeå, Uppsala
2025-03-14
Recruiting
Karolinska Institutet
Not applicable
1,000
Gävle, Halmstad, Linköping, Malmö, Umeå, Västerås
2025-03-03
Active, closed
Amgen
Phase 3
707
Gothenburg, Lund, Stockholm, Umeå
2024-12-09
Recruiting
Umeå University
Observational
15
Umeå
2024-12-09
Recruiting
Hypertension and Cerebrovascular Hemodynamics in General Anaesthesia
NCT06855407Anesthesia, Cerebral Blood Flow, Regional Cerebral Oxygen Saturation, Blood Pressure
Umeå University
Not applicable
30
Umeå
2024-12-06
By invitation
A Study to Evaluate Vutrisiran in Patients With Transthyretin Amyloidosis With Cardiomyopathy
NCT06679946Transthyretin Amyloidosis (ATTR) With Cardiomyopathy
DrugVutrisiran
Alnylam Pharmaceuticals
Phase 3
700
Gothenburg, Solna, Umeå
2024-12-03
Recruiting
Umeå University
Not applicable
176
Falun, Östersund, Södra Sunderbyn, Karlstad, Umeå, Sundsvall, Örebro
2024-11-20
Active, closed
Umeå University
Not applicable
80
Umeå
2024-11-06
Active, closed
Novartis Pharmaceuticals
Phase 2
251
Malmö, Stockholm, Umeå
2024-10-17
Recruiting
Region Västerbotten
Phase 3
60
Malmö, Umeå
2024-10-14
Recruiting
Bayer
Phase 3
555
Umeå, Lund
2024-08-28
Recruiting
First in Human (FIH) Study of ALN-SOD in Adult Participants With Amyotrophic Lateral Sclerosis Associated With Mutation in the SOD1 Gene (SOD1-ALS)
NCT06351592Amyotrophic Lateral Sclerosis (ALS), Mutation in the Superoxide Dismutase-1 (SOD1) Gene
Regeneron Pharmaceuticals
Phase 1/2
54
Umeå, Huddinge
2024-08-28
Active, closed
Uppsala University
Not applicable
110
Örebro, Uppsala, Umeå, Gothenburg
2024-08-12
Active, closed
UniQure Biopharma B.V.
Phase 1/2
20
Umeå
2024-08-01
Recruiting
Vastra Gotaland Region
Phase 3
40
Gothenburg, Linköping, Lund, Stockholm, Umeå, Uppsala
2024-06-10
Recruiting
Andreas Josefsson
Observational
5,500
Umeå
2024-06-10
By invitation
Region Västerbotten
Not applicable
141
Lund, Umeå
2024-05-01
Recruiting
Mediastinal EBUS Cryobiopsy Study In Sweden
NCT06347939Mediastinal Lymphadenopathy, Lung Cancer, Sarcoidosis, Lymphoma
Region Skane
Observational
200
Lund, Umeå
2024-04-01
Recruiting
EPIGUT: EPILEPSY AND GASTROINTESTINAL MICROBIOTA: UNDERSTANDING THERAPY RESPONSE
NCT07253701Epilepsy, Microbiota, Proteomics, Metabolomics
Karolinska Institutet
Observational
1,500
Gothenburg, Linköping, Lund, Stockholm, Umeå, Uppsala
2024-02-27
Recruiting
AstraZeneca
Phase 3
5,250
Gothenburg, Höllviken, Kungsbacka, Lund, Örebro, Stockholm, Umeå, Uppsala
2024-02-21
Active, closed
Study Evaluating Tarlatamab After Chemoradiotherapy in Limited-Stage Small-Cell Lung Cancer (LS-SCLC)
NCT06117774Limited Stage Small Cell Lung Cancer, Small Cell Lung Cancer
DrugTarlatamab
Amgen
Phase 3
404
Gothenburg, Umeå
2024-02-20
Recruiting
Umeå University
Observational
160
Umeå
2024-01-30
Recruiting
Nordlandssykehuset HF
Not applicable
50
Stockholm, Umeå
2024-01-27
Active, closed
Janssen Research & Development, LLC
Phase 3
838
Lund, Umeå, Uppsala, Varberg
2024-01-22
By invitation
Umeå University
Not applicable
512
Umeå
2024-01-20
Recruiting
Swedish CArdioPulmonary bioImage Study 2
NCT06679777Cardiovascular Diseases, Lung Diseases
Karolinska Institutet
Observational
30,154
Gothenburg, Linköping, Lund, Stockholm, Umeå, Uppsala
2024-01-15
Recruiting
Intellia Therapeutics
Phase 3
1,200
Stockholm, Umeå
2023-12-13
Recruiting
Treatment of Hypertrichosis With Intense Pulsed Light
NCT05775328Hypertrichosis, Hirsutism - Hypertrichosis
Alexander Shayesteh
Observational
39
Umeå
2023-12-01
Recruiting
Vastra Gotaland Region
Phase 3
240
Gothenburg, Linköping, Lund, Stockholm, Umeå, Uppsala
2023-12-01
Recruiting
Amgen
Phase 3
750
Gävle, Gothenburg, Umeå
2023-11-16
Recruiting
Umeå University
Not applicable
208
Umeå
2023-11-09
Recruiting
European Study of Prodromal iNPH
NCT05910944Normal Pressure Hydrocephalus, Hydrocephalus
Johan Virhammar
Observational
140
Gothenburg, Linköping, Stockholm, Umeå, Uppsala
2023-11-01
Recruiting
Caroline Lilliecreutz
Observational
600
Lund, Gothenburg, Linköping, Stockholm, Trollhättan, Umeå, Uppsala
2023-11-01
Recruiting
Karolinska University Hospital
Phase 2
370
Malmö, Örebro, Stockholm, Umeå, Uppsala
2023-10-26
Recruiting
DESTINY Breast Respond HER2-(Ultra)Low Europe
NCT05945732Unresectable Breast Cancer, Metastatic Breast Cancer, HER2-low Expressing Breast Cancer, HER2-(Ultra)Low Expressing Breast Cancer
DrugTrastuzumab deruxtecan
Daiichi Sankyo Europe, GmbH, a Daiichi Sankyo Company
Observational
2,295
Eskilstuna, Gävle, Jönköping, Örebro, Stockholm, Sundsvall, Umeå, Västerås
2023-10-24
Recruiting
Pain After Cardiac Arrest and Resuscitation (PAINCARE)
NCT07564778Pain, Out-of-hospital Cardiac Arrest (OHCA)
Region Skane
Observational
300
Halmstad, Malmö, Umeå
2023-10-15
Recruiting
Region Skane
Not applicable
76
Lund, Umeå
2023-09-25
Recruiting
Rescue of Nephrons With ALE.F02 (RENAL-F02)
NCT06047171Glomerulonephritis Rapidly Progressive
DrugsCyclophosphamid·Rituximab
Alentis Therapeutics AG
Phase 2
80
Linköping, Umeå
2023-09-07
Recruiting
Para-aortic Lymph Node Metastasis in Resectable Pancreatic Cancer
NCT06065891Pancreas Cancer, Pancreas Adenocarcinoma, Lymph Node Metastasis
Jon Unosson
Not applicable
300
Gothenburg, Linköping, Lund, Umeå, Uppsala
2023-09-05
Recruiting
Blood Pressure Treatment in ICU Patients with Subarachniodal Haemorrhage.
NCT06033378Blood Pressure, Subarachnoid Hemorrhage, Aneurysm Cerebral
Umeå University
Not applicable
30
Umeå
2023-09-01
Recruiting
AstraZeneca
Observational
52,121
Södertälje, Umeå
2023-08-21
Recruiting
Aarhus University Hospital
Not applicable
400
Gothenburg, Lund, Stockholm, Umeå
2023-08-02
By invitation
Long-Term Follow-Up (LTFU) of Subjects Dosed With NTLA-2001
NCT05697861Transthyretin-Related (ATTR) Familial Amyloid Polyneuropathy, Transthyretin-Related (ATTR) Familial Amyloid Cardiomyopathy, Wild-Type Transthyretin Cardiac Amyloidosis
Intellia Therapeutics
Observational
72
Umeå
2023-07-10
Recruiting
Population Health Research Institute
Not applicable
5,100
Huddinge, Jönköping, Karlstad, Lund, Stockholm, Umeå, Uppsala
2023-06-22
Recruiting
Prognostic and Diagnostic Added Value of Medical Imaging in Gynecological Cancer (PRODIGYN)
NCT05855941Cervix Cancer, Endometrial Cancer, Epithelial Ovarian Cancer
Region Västerbotten
Observational
120
Umeå
2023-05-23
Recruiting
Unilateral Primary Aldosteronism, Mineralocorticoid Antagonists Versus Surgical Treatment
NCT05797558Primary Hyperaldosteronism Due to Adrenal Adenoma
DrugEplerenone
Göteborg University
Not applicable
80
Gothenburg, Stockholm, Umeå
2023-04-28
Recruiting
Use of GnRHa During Chemotherapy for Fertility Protection
NCT05328258Breast Cancer Female, Acute Leukemia, Lymphoma, Osteosarcoma
DrugElacestrant
Kenny Rodriguez-Wallberg
Phase 3
500
Gothenburg, Lund, Örebro, Stockholm, Umeå
2023-03-31
Active, closed
Umeå University
Not applicable
48
Mora, Gällivare, Skellefteå, Umeå
2023-03-29
Recruiting
ULtrafiltration-Rate Induced CArdiac Strain (ULRICA) - Study
NCT06153888Fluid Overload, Dialysis; Complications
Umeå University
Not applicable
40
Umeå
2023-03-20
Recruiting
Remote Neuropsychological Assessment of Patients With Neurological Disorders and Injuries
NCT05819008Traumatic Brain Injury, Stroke, Multiple Sclerosis, Parkinson Disease
Umeå University
Observational
350
Umeå
2023-03-10
Recruiting
Stroke Prophylaxis With Apixaban in Chronic Kidney Disease Stage 5 Patients With Atrial Fibrillation
NCT05679024Chronic Kidney Diseases, Atrial Fibrillation, Stroke, Intracerebral Hemorrhage
Region Stockholm
Phase 3
1,400
Falun, Östersund, Mora, Kalmar, Kalix, Lund, Malmö, Umeå
2023-02-17
Recruiting
Princess Maxima Center for Pediatric Oncology
Phase 3
160
Gothenburg, Linköping, Lund, Stockholm, Umeå, Uppsala
2022-12-15
Recruiting
AstraZeneca
Phase 3
3,527
Helsingborg, Huddinge, Lund, Malmö, Solna, Stockholm, Umeå, Västerås
2022-12-13
Recruiting
Umeå University
Not applicable
60
Umeå
2022-12-01
Recruiting
Karolinska Institutet
Not applicable
712
Stockholm, Gothenburg, Lidköping, Sundsvall, Umeå, Västerås
2022-11-09
Recruiting
Sven Löffeler
Phase 3
980
Falun, Gothenburg, Helsingborg, Örebro, Östersund, Stockholm, Umeå, Uppsala
2022-11-04
Recruiting
Umeå University
Not applicable
420
Umeå
2022-10-31
Recruiting
Stereotactic Ablative Radiotherapy for OligoMetastatic Breast Cancer
NCT05377047Breast Cancer Stage IV, Oligometastatic Disease
Vastra Gotaland Region
Phase 3
345
Jönköping, Malmö, Stockholm, Umeå, Örebro, Gothenburg
2022-09-19
Active, closed
Umeå University
Not applicable
70
Umeå
2022-09-09
By invitation
Umeå University
Not applicable
40
Umeå
2022-09-06
Recruiting
The eHealth Diabetes Remission Trial
NCT05491005Diabetes Mellitus, Type 2
Umeå University
Not applicable
106
Jönköping, Örnsköldsvik, Umeå
2022-08-31
Recruiting
Umeå University
Observational
45
Umeå
2022-08-25
Recruiting
University Hospital, Linkoeping
Phase 2
40
Eksjö, Gothenburg, Jönköping, Linköping, Umeå, Värnamo, Västervik
2022-07-12
Recruiting
The Glaucoma Nicotinamide Trial
NCT05275738Glaucoma
Umeå University
Not applicable
660
Stockholm, Umeå
2022-05-18
Active, closed
MedTrace Pharma A/S
Phase 3
215
Gothenburg, Umeå
2022-05-08
Active, closed
Pierre Fabre Medicament
Phase 3
815
Stockholm, Umeå
2022-05-02
Recruiting
Survival, Quality of Life and Resectability in Locally Advanced Pancreatic Cancer
NCT05356039Pancreas Cancer, Pancreas Neoplasm, Pancreas Disease, Pancreas Adenocarcinoma
Umeå University
Observational
300
Umeå
2022-04-19
Recruiting
Scandinavian Humeral Diaphyseal Fracture Trial
NCT04574336Fracture Humerus of Shaft
Kolding Sygehus
Not applicable
287
Stockholm, Umeå, Uppsala
2022-04-04
Active, closed
Region Skane
Not applicable
288
Gothenburg, Lund, Stockholm, Umeå
2022-03-28
Recruiting
Mesalamine for Colorectal Cancer Prevention Program in Lynch Syndrome
NCT04920149Lynch Syndrome, Colon Cancer, Colon Neoplasm
Drugs5-ASA·Mesalazine·Mesalamine
Ann-Sofie Backman
Phase 2
150
Gothenburg, Malmö, Stockholm, Umeå, Uppsala
2022-03-21
Recruiting
Strategic Use of Big Data in Spine Surgery - Testing Digital Prediction of Outcome in Clinical Praxis
NCT05817747Constriction, Pathologic, Spine Degeneration, Surgery, Radiculopathy
Sahlgrenska University Hospital
Not applicable
900
Ängelholm, Malmö, Gothenburg, Stockholm, Sundsvall, Umeå, Uppsala
2022-03-01
Active, closed
Merck Sharp & Dohme LLC
Phase 3
280
Lund, Stockholm, Umeå
2022-02-03
Active, closed
Ionis Pharmaceuticals, Inc.
Phase 3
151
Umeå
2022-01-04
Active, closed
Umeå University
Phase 3
7,000
Umeå
2022-01-01
Active, closed
Smith & Nephew, Inc.
Observational
299
Umeå
2021-12-21
Recruiting
Region Västerbotten
Observational
60
Stockholm, Umeå
2021-12-14
Active, closed
Janssen Research & Development, LLC
Phase 3
776
Gothenburg, Linköping, Lund, Umeå, Uppsala
2021-11-17
Recruiting
Metastasis Directed Stereotactic Body Radiotherapy for Oligo Metastatic Hormone Sensitive Prostate Cancer
NCT04983095Prostate Cancer Metastatic, Radiation Therapy, Positron-Emission Tomography
Karin Soderkvist
Not applicable
118
Lund, Stockholm, Umeå, Jönköping, Örebro
2021-10-27
Active, closed
Janssen Research & Development, LLC
Phase 3
587
Falun, Gothenburg, Helsingborg, Luleå, Lund, Umeå, Uppsala
2021-10-14
Recruiting
Prognostic Factors in Periampullary Tumors and Cysts
NCT05155878Pancreas Cancer, Pancreas Neoplasm, Pancreas Cyst, Pancreatic Fistula
Umeå University
Observational
500
Umeå
2021-09-01
Active, closed
StUdy oN Burst Fractures (SunBurst)
NCT05003180Thoracolumbar Burst Fracture
Uppsala University
Not applicable
202
Gothenburg, Linköping, Malmö, Stockholm, Umeå, Uppsala, Halmstad, Jönköping
2021-09-01
Active, closed
Vegan Diet in Small Children
NCT05442281Vegan Diet
Umeå University
Observational
60
Umeå
2021-09-01
Active, closed
Ionis Pharmaceuticals, Inc.
Phase 3
89
Umeå
2021-06-14
Active, closed
Biogen
Phase 3
158
Umeå
2021-05-17
Recruiting
Alexander Valdman
Not applicable
254
Stockholm, Gävle, Gothenburg, Linköping, Lund, Sundsvall, Umeå, Uppsala
2021-04-20
Active, closed
Merck Sharp & Dohme LLC
Phase 3
1,688
Jönköping, Stockholm, Uppsala, Umeå, Gothenburg
2021-04-14
Recruiting
Umeå University
Not applicable
100
Gothenburg, Lund, Umeå, Uppsala
2021-04-07
Active, closed
POINT Biopharma, a wholly owned subsidiary of Eli Lilly and Company
Phase 3
455
Gothenburg, Umeå
2021-02-25
Recruiting
AB Science
Phase 3
495
Karlstad, Malmö, Umeå
2021-02-02
Recruiting
Effect of Fetal Aortic Valvuloplasty on Outcomes
NCT05386173Congenital Heart Disease, Aortic Valve Stenosis, Fetal Cardiac Disorder, Hypoplastic Left Heart Syndrome
Queen Silvia Children's Hospital, Gothenburg, Sweden
Observational
200
Lund, Stockholm, Umeå
2021-01-01
Active, closed
Pfizer
Phase 3
841
Solna, Uppsala, Umeå, Gothenburg, Stockholm
2020-12-21
Recruiting
Dysphagia After Anterior Cervical Spine Surgery
NCT04855838Dysphagia, Cervical Spinal Cord Injury
Umeå University
Not applicable
60
Umeå
2020-12-17
Recruiting
Karolinska University Hospital
Phase 3
1,020
Linköping, Lund, Örebro, Stockholm, Umeå, Uppsala
2020-11-27
Active, closed
Bayer
Phase 3
402
Stockholm, Uppsala, Umeå, Gothenburg
2020-10-20
Active, closed
Umeå University
Not applicable
200
Umeå
2020-10-19
Active, closed
Annika Bergquist
Phase 3
571
Malmö, Umeå, Gothenburg, Karlstad, Lidköping, Örebro, Stockholm, Uppsala
2020-10-01
Recruiting
Umeå University
Not applicable
130
Umeå
2020-09-29
Recruiting
Umeå University
Not applicable
1,106
Umeå
2020-08-26
Recruiting
Mats Heyman
Phase 3
6,430
Gothenburg, Linköping, Lund, Örebro, Stockholm, Umeå, Uppsala
2020-07-13
Active, closed
Supramarginal Resection in Glioblastoma
NCT04243005Glioblastoma
St. Olavs Hospital
Not applicable
90
Gothenburg, Stockholm, Umeå, Uppsala
2020-07-01
Active, closed
Merck Sharp & Dohme LLC
Phase 3
755
Jönköping, Malmö, Stockholm, Umeå
2020-02-27
Recruiting
Umeå University
Phase 3
200
Umeå
2020-01-01
Active, closed
RhoVac APS
Phase 2
180
Gothenburg, Malmö, Örebro, Stockholm, Umeå
2019-11-19
Recruiting
High-Risk Neuroblastoma Study 2 of SIOP-Europa-Neuroblastoma (SIOPEN)
NCT04221035High-Risk Neuroblastoma, Patient With Insufficient Response Chemoimmunotherapy
DrugsDinutuximab Beta·Vindesine·Cyclophosphamid·Thiotepa
Gustave Roussy, Cancer Campus, Grand Paris
Phase 3
800
Gothenburg, Linköping, Lund, Stockholm, Umeå, Uppsala
2019-11-05
By invitation
A Study Evaluating the Long-Term Efficacy and Safety of Ralinepag in Subjects With PAH Via an Open-Label Extension
NCT03683186PAH, Pulmonary Hypertension, Pulmonary Arterial Hypertension, Hypertension
United Therapeutics
Phase 3
1,000
Gothenburg, Linköping, Umeå
2019-09-23
Recruiting
Katarina Hedin
Phase 4
260
Jönköping, Linköping, Malmö, Umeå, Vaxjo
2019-09-09
Recruiting
Uppsala University Hospital
Not applicable
75
Gothenburg, Lund, Örebro, Solna, Umeå, Uppsala
2019-09-01
Recruiting
Mats Heyman
Observational
500
Gothenburg, Linköping, Lund, Örebro, Stockholm, Umeå, Uppsala
2019-08-29
Recruiting
University Hospital Muenster
Phase 3
683
Gothenburg, Linköping, Lund, Stockholm, Umeå, Uppsala
2019-08-23
Recruiting
Bristol-Myers Squibb
Phase 2
1,500
Gothenburg, Malmö, Umeå
2019-08-09
Active, closed
Merck Sharp & Dohme LLC
Phase 3
595
Jönköping, Stockholm, Uppsala, Umeå, Gothenburg
2019-07-24
Active, closed
Physical, Psychological and Socioeconomic Effects of Childhood Onset Diabetes in Sweden
NCT06883318Type 1 Diabetes Mellitus (T1DM), End-Stage Renal Disease
Umeå University
Observational
115,000
Umeå
2019-05-08
Active, closed
Institut de Recherches Internationales Servier
Phase 3
856
Falun, Jönköping, Örebro, Solna, Umeå
2019-03-21
Active, closed
Intra-operative Pancreatoscopy in Patients With IPMN
NCT03729453Intraductal Papillary Mucinous Neoplasm
Boston Scientific Corporation
Observational
100
Umeå
2019-03-20
Active, closed
Human Milk Fortification in Extremely Preterm Infants
NCT03797157Necrotizing Enterocolitis, Sepsis, Mortality
Thomas Abrahamsson, MD, PhD
Phase 2/3
229
Gothenburg, Linköping, Stockholm, Umeå, Uppsala
2019-02-01
Recruiting
Stefan Carlsson
Phase 3
450
Gothenburg, Stockholm, Umeå, Örebro
2018-10-30
Recruiting
Umeå University
Not applicable
700
Umeå
2018-09-19
Recruiting
Deep Brain Stimulation for Obsessive-compulsive Disorder
NCT06628752Obsessive-Compulsive Disorder
Umeå University
Not applicable
26
Umeå
2018-09-11
Recruiting
Merck Sharp & Dohme LLC
Phase 3
3,500
Stockholm, Uppsala, Umeå, Gothenburg
2018-08-21
Recruiting
The Swedish Essential Tremor (SWEET) Trial
NCT03832712Essential Tremor
Karolinska Institutet
Not applicable
100
Gothenburg, Linköping, Lund, Stockholm, Umeå, Uppsala
2018-06-30
Active, closed
Vastra Gotaland Region
Phase 4
2,201
Gothenburg, Karlskrona, Linköping, Lund, Örebro, Stockholm, Umeå, Uppsala
2018-06-29
Recruiting
Study on Proton Radiotherapy of Thymic Malignancies
NCT04822077Cardiotoxicity, Pulmonary Toxicity, Thymus Neoplasms
Ass. Prof. Jan Nyman
Not applicable
40
Umeå, Stockholm, Gothenburg
2018-04-18
Recruiting
Jeanette Lundin
Phase 1/2
50
Falun, Gävle, Lund, Gothenburg, Örebro, Stockholm, Umeå, Uppsala
2018-02-23
Active, closed
Pfizer
Phase 3
1,054
Gothenburg, Solna, Umeå
2017-12-18
Active, closed
Aspirin in Colorectal Cancer Liver Metastases
NCT03326791Colorectal Cancer Liver Metastases, Colorectal Cancer, Liver Metastases
DrugsAcetylsalicylic acid·Aspirin
Oslo University Hospital
Phase 2/3
466
Gothenburg, Linköping, Lund, Stockholm, Uppsala, Umeå
2017-12-15
Active, closed
University Hospital Muenster
Phase 3
650
Gothenburg, Linköping, Lund, Stockholm, Umeå, Uppsala
2017-08-03
Recruiting
Prostate Cancer Clinical Trials Consortium
Observational
5,000
Malmö, Umeå, Örebro
2017-07-21
Active, closed
Eli Lilly and Company
Phase 3
5,637
Malmö, Umeå, Sundsvall, Västerås, Vaxjo
2017-07-12
Active, closed
Lateral Episiotomy or Not in Vacuum Assisted Delivery in Non-parous Women
NCT02643108Pelvic Floor Disorders, Fecal Incontinence, Dystocia, Fetal Hypoxia
Karolinska Institutet
Not applicable
717
Falun, Gothenburg, Helsingborg, Stockholm, Umeå, Uppsala, Vaxjo
2017-06-30
Active, closed
Persona Partial Knee Clinical Outcomes Study
NCT03034811Osteoarthritis, Avascular Necrosis, Traumatic Arthritis, Conditional Tibial Condyle or Plateau Fractures
Zimmer Biomet
Not applicable
757
Umeå
2017-02-08
Active, closed
BROnchoalveolar Investigations of Never-smokers With Chronic Obstruction From the Swedish CardioPulmonary bioImage Study
NCT03049202Chronic Obstructive Pulmonary Disease, Emphysema, Chronic Bronchitis, Airway Obstruction
Karolinska Institutet
Observational
1,000
Stockholm, Gothenburg, Linköping, Lund, Umeå, Uppsala
2017-02-01
Active, closed
Astellas Pharma Global Development, Inc.
Phase 2
900
Gothenburg, Umeå
2016-12-22
Active, closed
Uppsala University
Not applicable
2,008
Gothenburg, Linköping, Luleå, Örebro, Sundsvall, Umeå, Uppsala, Vaxjo
2016-10-03
Active, closed
Oslo University Hospital
Phase 2/3
140
Gothenburg, Huddinge, Linköping, Lund, Umeå, Uppsala
2016-09
Active, closed
Vastra Gotaland Region
Not applicable
74
Gothenburg, Linköping, Lund, Örebro, Stockholm, Umeå, Uppsala
2016-06
Active, closed
Aragon Pharmaceuticals, Inc.
Phase 3
1,052
Gothenburg, Malmö, Örebro, Stockholm, Umeå, Uppsala, Vaxjo
2015-11-27
Active, closed
Aragon Pharmaceuticals, Inc.
Phase 3
1,503
Örebro, Stockholm, Umeå
2015-11-19
Recruiting
Proton Radiotherapy for Primary Central Nervous System Tumours in Adults
NCT02797366Central Nervous System Tumour, Arteriovenous Malformation
Uppsala University
Phase 2
500
Gothenburg, Linköping, Örebro, Stockholm, Umeå, Uppsala
2015-08
Recruiting
Surgery for Recurrent Glioblastoma
NCT02394626Glioblastoma
Insel Gruppe AG, University Hospital Bern
Phase 2
120
Gothenburg, Umeå
2015-05-01
Active, closed
Umeå University
Not applicable
100
Umeå
2015-01-01
Active, closed
Safety and Efficacy Study of Enzalutamide Plus Leuprolide in Patients With Nonmetastatic Prostate Cancer (EMBARK)
NCT02319837Hormone Sensitive Prostate Cancer, Prostate Cancer, Cancer of the Prostate
DrugsLupron·Eligard·Leuprorelin·Xtandi
Pfizer
Phase 3
1,068
Gothenburg, Malmö, Örebro, Stockholm, Umeå, Uppsala
2014-12-17
Active, closed
Neoadjuvant Response-guided Treatment of HER2 Positive Breast Cancer
NCT02568839Early-Stage Breast Carcinoma, HER-2 Positive Breast Cancer
DrugsTrastuzumab emtansine·Pertuzumab·Trastuzumab·Docetaxel
Thomas Hatschek
Phase 2/3
202
Örebro, Gothenburg, Lund, Stockholm, Sundsvall, Umeå, Uppsala
2014-11
Recruiting
Cerebellar Mutism Syndrome Study
NCT02300766Infratentorial Neoplasms, Mutism
Copenhagen University Hospital, Rigshospitalet
Observational
2,000
Gothenburg, Linköping, Skåne, Stockholm, Umeå, Uppsala
2014-10
Active, closed
Norwegian University of Science and Technology
Not applicable
177
Gävle, Gothenburg, Lund, Örebro, Stockholm, Umeå
2014-07-08
Active, closed
AstraZeneca
Phase 3
1,837
Gothenburg, Linköping, Malmö, Solna, Stockholm, Umeå
2014-04-22
Recruiting
Antiangiogenic Therapy for Children With Recurrent Medulloblastoma, Ependymoma, ATRT and Rare CNS Tumors
NCT01356290Medulloblastoma Recurrent, Ependymoma Recurrent, ATRT Recurrent, Rare CNS Tumor Recurrent
DrugsThalidomide·Celecoxib·Temozolomide·Cytarabine
Medical University of Vienna
Phase 2
232
Gothenburg, Linköping, Lund, Stockholm, Umeå, Uppsala
2014-04
Active, closed
Aragon Pharmaceuticals, Inc.
Phase 3
1,207
Gothenburg, Örebro, Stockholm, Umeå, Uppsala
2013-10-14
Active, closed
MedImmune LLC
Phase 2
571
Linköping, Lund, Umeå
2013-05-17
Active, closed
Umeå University
Not applicable
3,532
Umeå
2013-04-07
Active, closed
The SCAPIS-Snus Study
NCT07573319Nicotine, Mental Health, Cardiovascular (CV) Risk, Metabolic Abnormalities
Karolinska Institutet
Observational
30,154
Gothenburg, Lund, Stockholm, Umeå, Uppsala
2013-01-01
Active, closed
Trial on Three Treatments for Scoliosis
NCT01761305Idiopathic Scoliosis
Karolinska Institutet
Not applicable
135
Eskilstuna, Jönköping, Linköping, Stockholm, Sundsvall, Umeå, Västerås
2013-01
Recruiting
Multicenter Study for Diagnosis and Treatment of Perianal Abscesses
NCT02306382Perianal Abscess, Anal Fistulas, Incontinence
University Hospital, Umeå
Not applicable
200
Umeå
2012-12
Active, closed
Swedish Iodine in Pregnancy and Development in Children (SWIDDICH) Study
NCT02378246Thyroid Gland; Node, Pregnancy, Cognitive Developmental Delay
Göteborg University
Not applicable
1,337
Umeå, Gothenburg, Linköping, Skövde
2012-11
Rows per page Showing 1–195 of 195
1
Cite this view

Priya Life Science (2026). Clinical trial register: studies with a Swedish investigative site, filtered. Derived from ClinicalTrials.gov. Retrieved 12 October 2026. https://priyalifescience.com/clinical-trials-sweden/city/ume

Query this register directly
GET /api/trials?country=in&status=recruiting&format=json Try it now →

About this register

This register is built from ClinicalTrials.gov, the trial registry run by the U.S. National Library of Medicine. It includes every study on the registry that lists at least one investigative site in Sweden and is recruiting, not yet recruiting, active but no longer recruiting, or enrolling by invitation: 2,219 studies in total at the last sync on 12 Oct 2026, 03:19 UTC. The full list can be downloaded as CSV or queried as JSON through the register API.

This page shows the 195 of those studies with a site in Umeå.

How many clinical trials are recruiting in Umeå?

116 of the 195 studies on this page are recruiting new participants as of the 12 Oct 2026, 03:19 UTC sync. A further 10 have not yet opened recruitment, 62 are active but closed to new participants, and 7 are enrolling by invitation only. Eligibility for any study is decided by its study team.

Summary by phase

Studies by phase (Umeå), 195 studies
PhaseStudiesRecruitingShare
Not applicable684134.9%
Phase 3643432.8%
Observational402920.5%
Phase 21396.7%
Phase 2/3402.1%
Phase 1/2321.5%
Phase 4311.5%

Most active sponsors

Lead sponsors with the most studies (Umeå)
Lead sponsorStudiesRecruiting
Umeå University4930
Karolinska Institutet116
AstraZeneca87
Region Skane64
Uppsala University63
Merck Sharp & Dohme LLC51
Region Västerbotten54
Vastra Gotaland Region53
Amgen31
Aragon Pharmaceuticals, Inc.30
Listing here is informational and not medical advice; eligibility is determined by each study team. See also the Ireland, UK, EU, USA and China registers.